Navigation Links
Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
Date:9/28/2007

SEATTLE, Sept. 28 /PRNewswire/ -- Every hour of every day, someone dies of melanoma in the United States, making this disease one of the fastest growing cancers in the U.S. and worldwide. Since 1975, the incidence rate of new melanomas has more than doubled-striking people of all ages, all races, all economic levels and both sexes. Currently, there are more new cases of melanoma than HIV/AIDS. The good news is that when melanoma is found early there is an excellent chance of recovery.

Katie Bunker is vivid testimony to that fact. Three years ago, at the age of 13, Katie was diagnosed with node-positive melanoma. She had several lymph nodes removed and was treated for a year with interferon. Today Katie is a healthy 16-year-old, but she has her skin checked every 6 months and she is very aware that she will live with the risk of melanoma for the rest of her life-or until a cure is found.

On Friday, November 2, 2007, Katie will co-chair the Northwest Melanoma Symposium: From Science to Survivorship, the first educational symposium for melanoma patients, family members and healthcare providers offered in the Northwest. Presented by the Melanoma Research Foundation (MRF) in partnership with the Seattle Cancer Care Alliance (SCCA), the symposium will take place in the Pelton Auditorium of the Fred Hutchinson Cancer Research Center, on South Lake Union in Seattle. The MRF is a national nonprofit organization focused on melanoma research, education and advocacy. The SCCA is an alliance of the University of Washington Medical Center (UWMC) and the Fred Hutchinson Cancer Research Center (FHCRC).

Coordinated and co-chaired by Dr. David Byrd, Professor of Surgery, UWMC, and Co-Director of the SCCA Melanoma Clinic, the symposium will feature Dr. John P. Fruehauf, Department of Medicine, UC Irvine, speaking on the Future Directions of Melanoma Research and Treatment. The Science part of the program will also include Dr. Byrd (When Lightning Strikes Twice: Dealing with Recurrence) and Dr. Zsolt Argenyi of the UWMC (Beyond the ABCD's: Melanoma Screening).

The Survivorship part of the program will open with Dr. Karen Syrala of the FHCRC (Surviving and Thriving After Melanoma) and Fran Lewis PhD RN of the UWMC (When Mom or Dad Have Melanoma: Helping the Child Manage). It will continue with Andrea Leiserowitz, MPT (Rehabilitation Issues for Melanoma Survivors), Sarah Washburn, MS RD CD (Nutritional Health in Cancer Survivorship), both of the SCCA, and Dr. Dan Labriola ND (Natural Medicine, Melanoma and Survivorship) of the Northwest Natural Health Specialty Care Clinic. The final session of the day will be delivered by the Reverend Debra Jarvis, SCCA General Oncology Outpatient Chaplain and NPR correspondent (It's Not About the Hair-or the Sun).

Registration starts at 7:30 am and presentations begin at 8:00 am. Lunch will be provided, and a reception will follow the conclusion of the program at 3:30. There is no charge for the symposium, but pre-registration is required.

The Melanoma Research Foundation was founded in 1996 by Diana Ashby, a melanoma patient, who lost her battle to the disease one year later. Today the organization has become the leading advocate for melanoma research and education and is the primary underwriter for the Society of Melanoma Research, an international organization of melanoma scientists. In 2006, the MRF raised over $1.8 million dollars which is currently being used to fund 14 research grants, host scientific forums, raise community awareness and provide educational resources for patients, family members and health care providers around the country. The Northwest symposium is made possible with an educational grant from Novartis Pharmaceuticals.

To register for the Northwest Melanoma Symposium, visit MRF's website at http://www.melanoma.org or call 1.800.673.1290.


'/>"/>
SOURCE Melanoma Research Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
3. Control Your siRNA Research
4. Getting Started with MicroRNA Research
5. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
6. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
7. Research Organics
8. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
9. A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)
10. Research Tools for Analysis of ZAP-70
11. Technical Specifications Accelerating Your Research with the BD FACSCanto High Throughput Sampler Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):